Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of August 29, 2012
  • Print
  • Share
  • E-mail
-
Back to Previous Page

Product Detail

Product Description Red Blood Cells Deglycerolized Leukocytes Reduced
Recall Number B-2292-12
Classification Class II
Code Info 084FT82947, 084FT83618, 084J96023, 084J96301, 084J97023, 084J98141, 084K55016, 084K58706, 084K60043, 084K60194, 084K62037, 084K62556, 084KM48320, 084Q13262, 084Q13611, 084Q13772, 084Q15707, 084Q17490, 084Q20457, 084Q22541, 084T21666, 084T21812, 084T21893, 084T22978, 084W62556, 084W62563, 084W66330, 084W69575, 084Z84745, 084Z86429, 084Z88735, 084Z90229
Product Distributed Qty 32
Reason For Recall Blood products, lacking proper documentation of antigen phenotyping, were distributed.

Event Detail

Event Id 40870
Product Type Biologics
Status Terminated
Recalling Firm American National Red Cross (The)
City Oakland
State CA
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2005-10-19
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern Blood products were released for distribution to consignees located in CA.
-
-